Can newer anti-diabetic therapies delay the development of diabetic nephropathy?

Can newer anti-diabetic therapies delay the development of diabetic nephropathy?

Type 2 diabetes mellitus (T2DM) is progressive in nature and leads to hyperglycemia-associated microvascular and macrovascular complications. Diabetic nephropathy (DN) is one of the most prominent microvascular complication induced by T2DM and is characterized by albuminuria and progressive loss of...

Full description

Bibliographic Details
Main Authors:	Sohail Aziz, Siti Maisharah Sheikh Ghadzi, Syed Azhar Syed Sulaiman, Nur Hafzan Md Hanafiah, Sabariah Noor Harun
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Journal of Pharmacy and Bioallied Sciences
Subjects:	ddp4i diabetes progression diabetic nephropathy glucagon-like peptide-1 agonist newer antidiabetics peroxisome proliferator-activated receptors-γ sglt-2i
Online Access:	http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2021;volume=13;issue=4;spage=341;epage=351;aulast=Aziz

Similar Items

Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia
by: Davide Viggiano
Published: (2023-10-01)

Diabetic nephropathy: newer therapeutic perspectives
by: Krishna C. Keri, et al.
Published: (2018-07-01)

Therapeutic Advances in Diabetic Nephropathy
by: Hanny Sawaf, et al.
Published: (2022-01-01)

The Efficacy of Canagliflozin on Type 2 Diabetic Nephropathy in Male Rats
by: Manal M.G. Mourad*, et al.
Published: (2023-07-01)

Ipragliflozin Ameliorates Diabetic Nephropathy Associated with Perirenal Adipose Expansion in Mice
by: Hideyuki Okuma, et al.
Published: (2021-07-01)

Pharmacometrics approaches and its applications in diabetes: An overview
by: Sohail Aziz, et al.
Published: (2021-01-01)

Overexpression of SGLT2 in the kidney of a P. gingivalis LPS-induced diabetic nephropathy mouse model
by: Koichiro Kajiwara, et al.
Published: (2021-08-01)

Newer Diabetes Management Options and Physical Fitness to Promote Cardiovascular Benefits
by: Eric Nylén
Published: (2022-08-01)

Association between Pro12Ala polymorphism and albuminuria in type 2 diabetic nephropathy
by: Yung‐Nien Chen, et al.
Published: (2020-07-01)

Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?
by: Yoshio Sumida, et al.
Published: (2020-07-01)

Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
by: Hua-Xing Huang, et al.
Published: (2021-11-01)

Clinical and functional characteristics of diabetic nephropathy in children
by: O. V. Kiselnikova, et al.
Published: (2018-07-01)

Racial/ethnic and socioeconomic disparities in the use of newer diabetes medications in the Look AHEAD study
by: Ahmed Elhussein, et al.
Published: (2022-02-01)

Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota
by: Ni Yinhua, et al.
Published: (2022-10-01)

SGLT2i relieve proteinuria in diabetic nephropathy patients potentially by inhibiting renal oxidative stress rather than through AGEs pathway
by: Xiao-chun Zeng, et al.
Published: (2024-02-01)

Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy
by: Shaomin Shi, et al.
Published: (2023-09-01)

Novel Antidiabetic Drugs and the Risk of Diabetic Retinopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Artur Małyszczak, et al.
Published: (2024-03-01)

Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation
by: Qichao Hu, et al.
Published: (2023-03-01)

An Overview of Diabetic Nephropathy
by: Alp Atasoy, et al.
Published: (2015-03-01)

DsbA-L interacting with catalase in peroxisome improves tubular oxidative damage in diabetic nephropathy
by: Yan Liu, et al.
Published: (2023-10-01)

Newer anticoagulants and their impact on interventional pain procedures
by: Babita Ghai, et al.
Published: (2017-01-01)

Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data
by: Kugler AJ, et al.
Published: (2018-05-01)

Editorial: Association between diabetic nephropathy and diabetic retinopathy or non-diabetic nephropathy
by: Haiyong Chen, et al.
Published: (2024-01-01)

Predictive factors for non-diabetic nephropathy in diabetic patients. The utility of renal biopsy
by: Sheila Bermejo, et al.
Published: (2016-09-01)

Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study)
by: Sho Kinguchi, et al.
Published: (2019-08-01)

Empagliflozin: a new strategy for nephroprotection in diabetes
by: Anton Ivanovich Korbut, et al.
Published: (2017-05-01)

Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report
by: Felice Nappi, et al.
Published: (2019-08-01)

Epigenetics in the pathogenesis of diabetic nephropathy
by: Li Xue, et al.
Published: (2021-12-01)

Clinical and Pathological Characteristics of Patients With Nonproteinuric Diabetic Nephropathy
by: Dong-Yuan Chang, et al.
Published: (2021-10-01)

Ginger and Diabetic Nephropathy: A Letter to the Editor
by: Mahmoud Rafieian-Kopaei, et al.
Published: (2014-04-01)

The care of the elderly with diabetic nephropathy in conservative treatment
by: Caren da Silva Jacobi, et al.
Published: (2013-09-01)

Effects of Smoking on Diabetic Nephropathy
by: Yasemin Gündoğdu, et al.
Published: (2022-02-01)

Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes
by: Hannah Seok, et al.
Published: (2013-10-01)

Chronic Administration of Visfatin Ameliorated Diabetic Nephropathy in Type 2 Diabetic Mice
by: Young Sun Kang, et al.
Published: (2016-05-01)

Mechanism of hypertension in diabetic nephropathy
by: Nazar Chaudhary Muhammad Junaid
Published: (2014-04-01)

Role of iNOS and eNOS expression in a group of Egyptian diabetic and nondiabetic nephropathy patients
by: Mayssa I. Aly, et al.
Published: (2013-01-01)

Zinc Status in Type 2 Diabetic Patients: Relation to the Progression of Diabetic Nephropathy
by: Dhia J. Al-Timimi, et al.
Published: (2014-11-01)

Morphological pattern of non-diabetic nephropathy in type 2 diabetes mellitus patients
by: Meral Mese, et al.
Published: (2022-06-01)

Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model
by: Xingxing An, et al.
Published: (2019-12-01)

Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study
by: Fukashi Ishibashi, et al.
Published: (2022-06-01)